Daoqi You

3.8k total citations
22 papers, 1.3k citations indexed

About

Daoqi You is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Daoqi You has authored 22 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 12 papers in Cancer Research and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Daoqi You's work include Cancer Genomics and Diagnostics (11 papers), Cellular transport and secretion (3 papers) and Advanced Breast Cancer Therapies (2 papers). Daoqi You is often cited by papers focused on Cancer Genomics and Diagnostics (11 papers), Cellular transport and secretion (3 papers) and Advanced Breast Cancer Therapies (2 papers). Daoqi You collaborates with scholars based in United States, Austria and United Kingdom. Daoqi You's co-authors include Aliaksandra Samoila, Thomas J. Melia, Sarat Chandarlapaty, Patricia Sung, José Baselga, Mary Ellen Moynahan, Parul Patel, Michael K. Rosen, James E. Rothman and Michael Gnant and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Genetics.

In The Last Decade

Daoqi You

19 papers receiving 1.3k citations

Peers

Countries citing papers authored by Daoqi You

Since Specialization

Citations

This map shows the geographic impact of Daoqi You's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daoqi You with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daoqi You more than expected).

Fields of papers citing papers by Daoqi You

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daoqi You. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daoqi You. The network helps show where Daoqi You may publish in the future.

Co-authorship network of co-authors of Daoqi You

This figure shows the co-authorship network connecting the top 25 collaborators of Daoqi You. A scholar is included among the top collaborators of Daoqi You based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daoqi You. Daoqi You is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Single-cell protein activity analysis reveals aberrant myogenesis and IGF2-PI3K pathway dependencies in MYOD1 -mutant rhabdomyosarcoma 2026 ·Science Advances ·(unknown), Fabio Vanoli, (unknown), (unknown), (unknown), (unknown), (unknown), Daoqi You, Franck Tirode, Patricia Sung, (unknown), (unknown), Leonard H. Wexler, Andrew L. Kung, (unknown), (unknown), (unknown), (unknown)	0
2	Supernumerary ring chromosome 1 syndrome leads to fusion-driven B-cell acute lymphoblastic leukemia in monozygotic twins 2025 ·Blood Advances ·Jesús Gutiérrez‐Abril, Gunes Gundem, Elise Fiala, (unknown), Noushin Farnoud, Daniel Leongamornlert, (unknown), Juan Arango Ossa, Dylan Domenico, Max F. Levine, (unknown), (unknown), Daoqi You, Michael F. Walsh, (unknown), Andrew L. Kung, Neerav Shukla, William L. Carroll, Elli Papaemmanuil	0
3	Abstract PR01: Identification and pharmacological targeting of treatment-resistant, stem-like breast cancer cells for combination therapy 2024 ·Cancer Research ·Jeremy Worley, (unknown), Daoqi You, Mikko Turunen, Hongxu Ding, Evan Paull, Aaron T. Griffin, Adina Grunn, (unknown), Erin Bush, (unknown), Prabhjot S. Mundi, Peter A. Sims, Piero Dalerba, Filemon S. Dela Cruz, Andrew L. Kung, Andrea Califano	1
4	Effects of LSD1 Inhibition with Img-7289 on the Leukemia Initiating Cell Population with Induction of Differentiation and Cell Death in Pediatric Relapsed/Refractory AML 2022 ·Blood ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Daoqi You, Andrew L. Kung, Filemon S. Dela Cruz	2
5	Translational Strategies for Repotrectinib in Neuroblastoma 2021 ·Molecular Cancer Therapeutics ·(unknown), Glorymar Ibáñez, (unknown), Audrey Mauguen, (unknown), Néstor Rosales, (unknown), (unknown), Daoqi You, (unknown), Stephen S. Roberts, Andrew L. Kung, Filemon S. Dela Cruz	8
6	Utility of Serial cfDNA NGS for Prospective Genomic Analysis of Patients on a Phase I Basket Study 2021 ·JCO Precision Oncology ·Lillian M. Smyth, Jonathan Reichel, Jiabin Tang, Juber Patel, Fanli Meng, (unknown), Brian Houck‐Loomis, Daoqi You, Aliaksandra Samoila, Gaia Schiavon, Bob T. Li, Pedram Razavi, Salvatore Piscuoglio, Jorge S. Reis‐Filho, Barry S. Taylor, José Baselga, David B. Solit, David M. Hyman, Michael F. Berger, Sarat Chandarlapaty	4
7	Preclinical evaluation of XPO1 inhibition in Wilms tumors. 2020 ·Journal of Clinical Oncology ·Michael V. Ortiz, (unknown), Daoqi You, Prabhjot S. Mundi, Lianna J. Marks, (unknown), Daniel Diolaiti, Mahalaxmi Aburi, Andrea Califano, Filemon S. Dela Cruz, Andrew L. Kung	0
8	Plasma KRAS as a biomarker for pancreatic ductal adenocarcinoma (PDAC). 2018 ·Journal of Clinical Oncology ·Benjamin A. Krantz, Dana W.Y. Tsui, Maeve A. Lowery, Marinela Capanu, Kenneth H. Yu, David P. Kelsen, Erika Gedvilaite, Liguo Zhang, S. Duygu Selçuklu, Daoqi You, Jennifer S. Golia Pernicka, Richard Kinh Gian, Christine A. Iacobuzio–Donahue, Eileen M. O’Reilly	2
9	Correlation between PIK3CA mutations in cell-free DNA and everolimus efficacy in HR+, HER2− advanced breast cancer: results from BOLERO-2 2017 ·British Journal of Cancer ·Mary Ellen Moynahan, David Chen, Wei He, Patricia Sung, Aliaksandra Samoila, Daoqi You, (unknown), Parul Patel, François Ringeisen, Gabriel N. Hortobágyi, José Baselga, Sarat Chandarlapaty	111
10	Four-month course of adjuvant dabrafenib in patients with surgically resected stage IIIC melanoma characterized by a BRAFV600E/K mutation 2017 ·Oncotarget ·Parisa Momtaz, James J. Harding, Charlotte E. Ariyan, Daniel G. Coit, Taha Merghoub, Billel Gasmi, Daoqi You, Agnès Viale, Katherine S. Panageas, Aliaksandra Samoila, Michael A. Postow, Jedd D. Wolchok, Paul B. Chapman	6
11	Plasma DNA-Based Molecular Diagnosis, Prognostication, and Monitoring of Patients With EWSR1 Fusion-Positive Sarcomas 2017 ·JCO Precision Oncology ·Neerav Shukla, Juber Patel, Heather Magnan, Ahmet Zehir, Daoqi You, Jiabin Tang, Fanli Meng, Aliaksandra Samoila, Emily K. Slotkin, Srikanth Ambati, Alexander J. Chou, Leonard H. Wexler, Paul A. Meyers, Ellinor I.B. Peerschke, Agnès Viale, Michael F. Berger, Marc Ladanyi	30
12	Phase I Study of Epigenetic Priming with Azacitidine Prior to Standard Neoadjuvant Chemotherapy for Patients with Resectable Gastric and Esophageal Adenocarcinoma: Evidence of Tumor Hypomethylation as an Indicator of Major Histopathologic Response 2016 ·Clinical Cancer Research ·Bryan J. Schneider, Manish A. Shah, Kelsey Klute, Allyson J. Ocean, E Popa, Nasser K. Altorki, Michael W. Lieberman, Andrew M. Schreiner, Rhonda K. Yantiss, Paul J. Christos, (unknown), Daoqi You, Agnès Viale, Pouneh Kermani, Joseph M. Scandura	51
13	Quantification of tumor-derived cell free DNA(cfDNA) by digital PCR (DigPCR) in cerebrospinal fluid of patients with BRAFV600 mutated malignancies 2016 ·Oncotarget ·Parisa Momtaz, Elena Pentsova, Omar Abdel‐Wahab, Eli L. Diamond, David M. Hyman, Taha Merghoub, Daoqi You, Billel Gasmi, Agnès Viale, Paul B. Chapman	52
14	Prevalence of ESR1 Mutations in Cell-Free DNA and Outcomes in Metastatic Breast Cancer 2016 ·JAMA Oncology ·Sarat Chandarlapaty, David Chen, Wei He, Patricia Sung, Aliaksandra Samoila, Daoqi You, (unknown), Parul Patel, Maurizio Voi, Michael Gnant, Gabriel Hortobagyi, José Baselga, Mary Ellen Moynahan	347
15	Somatic mutations in leukocytes infiltrating primary breast cancers 2015 ·npj Breast Cancer ·Maria Kleppe, Elizabeth Comen, Hannah Y. Wen, Lennart Bastian, (unknown), Franck Rapaport, Matthew D. Keller, (unknown), (unknown), Agnès Viale, Daoqi You, Robert Benezra, Britta Weigelt, Edi Brogi, Michael F. Berger, Jorge S. Reis‐Filho, Ross L. Levine, Larry Norton	37
16	Lipidic Antagonists to SNARE-mediated Fusion 2006 ·Journal of Biological Chemistry ·Thomas J. Melia, Daoqi You, David Tareste, James E. Rothman	31
17	SNAREs can promote complete fusion and hemifusion as alternative outcomes 2005 ·The Journal of Cell Biology ·Claudio G. Giraudo, Chuan Hu, Daoqi You, (unknown), Eugene V. Mosharov, David Sulzer, Thomas J. Melia, James E. Rothman	112
18	Imaging single membrane fusion events mediated by SNARE proteins 2004 ·Proceedings of the National Academy of Sciences ·(unknown), Thomas J. Melia, Jyoti K. Jaiswal, Joshua Z. Rappoport, Daoqi You, Thomas Söllner, James E. Rothman, Sanford M. Simon	124
19	Itk Functions to Control Actin Polymerization at the Immune Synapse through Localized Activation of Cdc42 and WASP 2003 ·Current Biology ·Christine M. Labno, Carol M. Lewis, Daoqi You, Daisy W. Leung, (unknown), (unknown), Abhinav Seth, Lisa D. Finkelstein, Michael K. Rosen, Pamela L. Schwartzberg, Janis K. Burkhardt	106
20	Constitutively activating mutation in WASP causes X-linked severe congenital neutropenia 2001 ·Nature Genetics ·Koenraad Devriendt, Annette S. Kim, (unknown), Suzanna G.M. Frints, Marianne Schwartz, Joost J. van den Oord, Gregor Verhoef, Marc Boogaerts, J. P. Fryns, Daoqi You, Michael K. Rosen, Peter Vandenberghe	298

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact